-
1
-
-
0032066478
-
13C-labelled prostacyclins
-
13C-labelled prostacyclins. Acta Chem Scand. 52:1998;635-640.
-
(1998)
Acta Chem Scand
, vol.52
, pp. 635-640
-
-
Björkman, M.1
Andersson, Y.2
Doi, H.3
Kato, K.4
Suzuki, M.5
Noyori, R.6
Watanabe, Y.7
Långström, B.8
-
4
-
-
0002291141
-
Radioligand disposition and metabolism. Key information in early drug development
-
D. Comar. Dordrecht: Kluwer Academic Publishers
-
Halldin C., Swahn C.-G., Farde L., Sedvall G. Radioligand disposition and metabolism. Key information in early drug development. Comar D., PET for drug development and evaluation. 1995;55-65 Kluwer Academic Publishers, Dordrecht.
-
(1995)
PET for drug development and evaluation
, pp. 55-65
-
-
Halldin, C.1
Swahn, C.-G.2
Farde, L.3
Sedvall, G.4
-
5
-
-
0025194627
-
3H]6-nitroquipazine binding sites in rat brain
-
3H]6-nitroquipazine binding sites in rat brain. Eur J Pharmacol. 180:1990;273-281.
-
(1990)
Eur J Pharmacol
, vol.180
, pp. 273-281
-
-
Hashimoto, K.1
Goromaru, T.2
-
7
-
-
0032773868
-
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter
-
Helfenbein J., Sandell J., Halldin C., Chalon S., Emond P., Okubo Y., Chou Y.-H., Frangin Y., Douziech L., Garreau L., Swahn C.-G., Besnard J.-C., Farde L., Guilloteau D. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. Nucl Med Biol. 26:1999;491-499.
-
(1999)
Nucl Med Biol
, vol.26
, pp. 491-499
-
-
Helfenbein, J.1
Sandell, J.2
Halldin, C.3
Chalon, S.4
Emond, P.5
Okubo, Y.6
Chou, Y.-H.7
Frangin, Y.8
Douziech, L.9
Garreau, L.10
Swahn, C.-G.11
Besnard, J.-C.12
Farde, L.13
Guilloteau, D.14
-
9
-
-
10144229103
-
Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter
-
Jagust W.J., Eberling J.L., Biegon A., Taylor S.E., VanBrocklin H.F., Jordan S., Hanrahan S.M., Roberts J.A., Brennan K.M., Mathis C.A. Iodine-123-5-iodo-6-nitroquipazine SPECT radiotracer to image the serotonin transporter . J Nucl Med. 37:1996;1207-1214.
-
(1996)
J Nucl Med
, vol.37
, pp. 1207-1214
-
-
Jagust, W.J.1
Eberling, J.L.2
Biegon, A.3
Taylor, S.E.4
VanBrocklin, H.F.5
Jordan, S.6
Hanrahan, S.M.7
Roberts, J.A.8
Brennan, K.M.9
Mathis, C.A.10
-
10
-
-
0027333620
-
11C]NNC 756 as new radioligands for the D1-dopamine receptor
-
11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113:1993;149-156.
-
(1993)
Psychopharmacology
, vol.113
, pp. 149-156
-
-
Karlsson, P.1
Farde, L.2
Halldin, C.3
Swahn, C.-G.4
Sedvall, G.5
Foged, C.6
Hansen, K.T.7
Skrumsager, B.8
-
11
-
-
0032805058
-
Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter
-
Lundkvist C., Loc'h C., Halldin C., Bottlaender M., Ottaviani M., Coulon C., Fuseau C., Mathis C., Farde L., Maziere B. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter. Nucl Med Biol. 26:1999;501-507.
-
(1999)
Nucl Med Biol
, vol.26
, pp. 501-507
-
-
Lundkvist, C.1
Loc'h, C.2
Halldin, C.3
Bottlaender, M.4
Ottaviani, M.5
Coulon, C.6
Fuseau, C.7
Mathis, C.8
Farde, L.9
Maziere, B.10
-
12
-
-
0025318248
-
Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter
-
Martin D.C., Introna R.P., Aronstam R.S. Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neuroscience Lett. 112:(1):1990;99-103.
-
(1990)
Neuroscience Lett
, vol.112
, Issue.1
, pp. 99-103
-
-
Martin, D.C.1
Introna, R.P.2
Aronstam, R.S.3
-
13
-
-
0027969320
-
Binding potency of 6-nitroquipazine analogues for the 5-hydroxytryptamine reuptake complex
-
Mathis C.A., Taylor S.E., Enas J.D., Akgün E. Binding potency of 6-nitroquipazine analogues for the 5-hydroxytryptamine reuptake complex. J Pharm Pharmacol. 46:1994;751-754.
-
(1994)
J Pharm Pharmacol
, vol.46
, pp. 751-754
-
-
Mathis, C.A.1
Taylor, S.E.2
Enas, J.D.3
Akgün, E.4
-
14
-
-
0028265462
-
Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter
-
Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression focus on the serotonin transporter . Clin Chem. 40:1994;288-295.
-
(1994)
Clin Chem
, vol.40
, pp. 288-295
-
-
Owens, M.J.1
Nemeroff, C.B.2
-
15
-
-
0034077167
-
2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): An improved serotonin transporter ligand
-
Oya S., Choi S.-R., Hou C., Mu M., Kung M.-P., Acton P.D., Siciliano M., Kung H. 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM) An improved serotonin transporter ligand . Nucl Med Biol. 27:2000;249-254.
-
(2000)
Nucl Med Biol
, vol.27
, pp. 249-254
-
-
Oya, S.1
Choi, S.-R.2
Hou, C.3
Mu, M.4
Kung, M.-P.5
Acton, P.D.6
Siciliano, M.7
Kung, H.8
-
16
-
-
0025610277
-
Clinical overview of serotonin reuptake inhibitors
-
Rickels K., Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry. 51:1990;9-12.
-
(1990)
J Clin Psychiatry
, vol.51
, pp. 9-12
-
-
Rickels, K.1
Schweizer, E.2
-
17
-
-
0000167464
-
11C]FLB 457 by use of the GE Medical Systems PETtrace MeI MicroLab
-
11C]FLB 457 by use of the GE Medical Systems PETtrace MeI MicroLab. J Labelled Compd Radiopharm. 42:1999;1183-1193.
-
(1999)
J Labelled Compd Radiopharm
, vol.42
, pp. 1183-1193
-
-
Sandell, J.1
Langer, O.2
Larsen, P.3
Dolle, F.4
Vaufrey, F.5
Demphel, S.6
Crouzel, C.7
Halldin, C.8
-
18
-
-
84985570392
-
The palladium-catalyzed cross-coupling reactions of organotin reagents with organic electrophiles
-
Stille J.K. The palladium-catalyzed cross-coupling reactions of organotin reagents with organic electrophiles. Angew Chem Int Ed Eng. 25:1986;508-524.
-
(1986)
Angew Chem Int Ed Eng
, vol.25
, pp. 508-524
-
-
Stille, J.K.1
-
19
-
-
0029036521
-
11C](+)McN5652
-
11C](+)McN5652. Synapse. 20:1995;37-43.
-
(1995)
Synapse
, vol.20
, pp. 37-43
-
-
Szabo, Z.1
Kao, P.F.2
Scheffel, U.3
Suehiro, M.4
Mathews, W.B.5
Ravert, H.T.6
Musachio, J.L.7
Marenco, S.8
Kim, S.E.9
Ricaurte, G.A.10
Wong, D.F.11
Wagner, H.N.12
Dannals, R.F.13
-
20
-
-
0029015240
-
Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus
-
Tejani-Butt S.M., Yang J., Pawlyk A.C. Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus. NeuroReport. 6:1995;1207-1210.
-
(1995)
NeuroReport
, vol.6
, pp. 1207-1210
-
-
Tejani-Butt, S.M.1
Yang, J.2
Pawlyk, A.C.3
-
21
-
-
0019781654
-
DU 24565, A quipazine derivative, a potent selective serotonin uptake inhibitor
-
Vaatstra W.J., Deiman-Van Aalst W.M.A., Eigeman L. DU 24565, A quipazine derivative, a potent selective serotonin uptake inhibitor. Eur J Pharmacol. 70:1981;195-202.
-
(1981)
Eur J Pharmacol
, vol.70
, pp. 195-202
-
-
Vaatstra, W.J.1
Deiman-Van Aalst, W.M.A.2
Eigeman, L.3
-
22
-
-
0028006399
-
The ECAT EXACT HR: Performance of a new high resolution positron scanner
-
Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W.-D. The ECAT EXACT HR Performance of a new high resolution positron scanner . J Comput Assist Tomogr. 18:1994;110-118.
-
(1994)
J Comput Assist Tomogr
, vol.18
, pp. 110-118
-
-
Wienhard, K.1
Dahlbom, M.2
Eriksson, L.3
Michel, C.4
Bruckbauer, T.5
Pietrzyk, U.6
Heiss, W.-D.7
|